In October 2001, when the first anthrax patients sought medical care, none of them had a history suggesting exposure to anthrax. Given the rarity of anthrax, many other causes more likely explained their early, nonspecific symptoms. The diversity of anthrax victims, which included an infant, revealed that biological terrorism could affect anyone, regardless of age, gender, health status, occupation, or socioeconomic status (1). The anthrax events also taught us that alert clinicians who recognize a potential terrorist-caused illness, obtain the appropriate laboratory tests, and notify public health officials, play a critical role in protecting their communities as well as their individual patients (1). Early warnings to local health officials, who work closely with law enforcement, can be successful in preventing additional casualties.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gerberding, JL, Hughes, JM, Koplan, JP. Bioterrorism Preparedness and Response. Clinicians and Public Health Agencies as Essential Partners. JAMA, 287(7):898–900, 2002.
Centers for Disease Control and Prevention. Framework for Evaluating Public Health Surveillance Systems for Early Detection of Outbreaks. Morbidity and Mortality Weekly Report 53(RR05):1–11, May 7, 2004.
Cherry, CL, Kainer, MA, Ruff, TA. Biological Weapons Preparedness: The Role of Physicians. Internal Medicine Journal, 33:242–253, 2003.
Gostin LO. Public Health Law: Power, Duty and Restraint. Turning Point. Collaborating for a New Century in Public Health. University of Washington, Turning Point National Program Office, December 1999. Available at http://www.turningpointprogram.org/Pages/pdfs/publications/gostin.pdf, last accessed 3–18–06.
Doyle, TJ, Glynn, MK, Groseclose, SL. Completeness of Notifiable Infectious Disease Reporting in the United States: An Analytical Literature Review. American Journal of Epidemiology, 155(9):866–874, 2002.
Centers for Disease Control and Prevention. HIPAA Privacy Rule and Public Health. Guidance from the CDC and the U.S. Department of Health and Human Services. Morbidity and Mortality Weekly Report (MMWR), 52(Supp. 1):1–12, May 2, 2003. Also at http://www.cdc.gov/mmwr/preview/mmwrhtml/su5201a1.htm (last accessed 3–18–06).
Buehler, JW, Berkelman, RL, Hartley, DM, Peters, CJ. Syndromic Surveillance and Bioterrorism-Related Epidemics. Emerging Infectious Diseases, 9(10):1197–1204, 2003.
Lewis, MD, Pavlin, JA, Mansfield, JL, O’Brien, S, Boomsma, LG, Elbert, YE, Kelley, PW. Disease Outbreak Detection System Using Syndromic Data in the Greater Washington DC Area. American Journal of Preventive Medicine, 23(3):180–186, 2002.
New York City, Department of Health and Mental Hygiene. Key Agency Impact–2003. http://www.nyc.gov/html/doh/downloads/pdf/public/accomplish_2003.pdf, last accessed 3–12–06.
Lazarus, R, Kleinman, KP, Dashevsky, I, DeMaria, A, Platt, R. Using Automated Medical Records for the Rapid Identification of Illness Syndromes (Syndromic Surveillance): The Example of Lower Respiratory Infection. BMC Public Health, 2001. http://www.biomedcentral.com/1471–2458/1/9, last accessed 3–12–06.
Mandl KD, Overhage JM, Wagner MM, et al. Implementing Syndromic Surveillance: A Practical Guide Informed by the Early Experience. Journal of the American Medical Informatics Association, 11(2):141–150, 2004.
Lazarus, R, Kleinman, KP, Dashevsky, I, Adams, C, Kludt, P, DeMaria, A, Platt, R. Use of Automated Ambulatory-Care Encounter Records for Detection of Acute Illness Clusters, Including Potential Bioterrorism Events. Emerging Infectious Diseases, 8(8):753–760, 2002.
Lober, WB, Trigg, LJ, Karras, BT, Bliss, D, Ciliberti, J, Stewart, L, Duchin, JS. Syndromic Surveillance Using Automated Collection of Computerized Discharge Diagnoses. Journal or Urban Health, 80(2, Suppl. 1):i97–i106, 2003.
Melnick, A. Introduction to Geographic Information Systems in Public Health, Jones and Bartlett Publishers, 2002.
Hupert, N, Mushlin, AI, Callahan, MA. Modeling the Public Health Response to Bioterrorism: Using Discrete Event Simulation to Design Antibiotic Distribution Centers. Medical Decision Making 22(Suppl.):S17–S25, 2002.
Centers for Disease Control and Prevention. Medical Offices and Clinics Pandemic Influenza Planning Checklist, Version 2.2, http://www.pandemicflu.gov/plan/medical.html, March 6, 2006 (last accessed 3–19–06).
Campos-Outcalt, D. Disaster Medical Response: Maximizing Your Effectiveness. The Journal of Family Practice, 55(2):113–116, 2006.
Hoard, ML and Tosatto, RJ. Medical Reserve Corps: Strengthening Public Health and Improving Preparedness. Disaster Management and Response 3(2):48–52, 2005.
United States Department of Health and Human Services, Office of the Surgeon General. Medical Reserve Corps Resource Site. http://www.medicalreservecorps.gov/page.cfm?pageID=5 (last accessed 3–26–06).
United States Department of Homeland Security, National Disaster Medical Systems. DMAT. http://www.oep-ndms.dhhs.gov/dmat.html (last accessed 3–26–06).
Partridge, R, Alexander, J, Lawrence, T, and Suner, S. Medical Counterbioterrorism: The Response to Provide Anthrax Prophylaxis to New York City US Postal Service Employees. Annals of Emergency Medicine, 41(4):441–446, 2003.
Saultz, JW (Ed.). Textbook of Family Medicine. New York: McGraw-Hill. 2000.
Rights and permissions
Copyright information
© 2008 Springer
About this chapter
Cite this chapter
(2008). The Primary Care Physician’s Role in Supporting the Public Health Response to Biological, Chemical, and Radiological Terrorism. In: Biological, Chemical, and Radiological Terrorism. Springer, New York, NY. https://doi.org/10.1007/978-0-387-47232-4_6
Download citation
DOI: https://doi.org/10.1007/978-0-387-47232-4_6
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-47231-7
Online ISBN: 978-0-387-47232-4
eBook Packages: MedicineMedicine (R0)